Start › Rak piersi › Wirginia › Richmond
Badania kliniczne dla Rak piersi w mieście Richmond, VA
26 badań dla Rak piersi szuka uczestników w ośrodkach w mieście Richmond i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekrutacjaZapraszamy zdrowych ochotników
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekrutacjaFaza 3
- Bon Secours Virginia Health System, Midlothian · 11 mi dalej
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- i 3 więcej
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RekrutacjaFaza 2
- Virginia Cancer Institute, Richmond
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekrutacjaFaza 3
- VCU Health Adult Outpatient Pavillion ( Site 0070), Richmond
- Bon Secours St. Francis Medical Center-Oncology Research ( Site 0015), Midlothian · 11 mi dalej
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekrutacjaFaza 3
- Research Site, Midlothian · 11 mi dalej
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekrutacjaFaza 3
- Bon Secours Cancer Institute at St. Francis ( Site 0048), Midlothian · 11 mi dalej
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekrutacjaFaza 3
- Clinical Trial Site, Midlothian · 11 mi dalej
Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
Rekrutacja
- Adult Outpatient Pavilion, Richmond
- Cellular Immunotherapies and Transplant Department, Richmond
- VCU Health at Stony Point, Richmond
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekrutacjaFaza 3
- Bon Secours Cancer Institute at St. Mary's, Richmond
- Bon Secours Cancer Institute at Memorial Regional, Mechanicsville · 6 mi dalej
- Bon Secours St. Francis Medical Center, Midlothian · 11 mi dalej
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekrutacjaFaza 3
- Virginia Cancer Institute, Richmond
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RekrutacjaFaza 3
- Research Site, Midlothian · 11 mi dalej
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekrutacjaFaza 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- i 4 więcej
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekrutacjaFaza 2/3
- Bon Secours St. Francis Medical Center, Midlothian · 11 mi dalej
E-Mindfulness Approaches for Living After Breast Cancer
RekrutacjaFaza 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Virginia Cancer Institute, Richmond
- i 4 więcej
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Rekrutacja
- Virgina Community University Massey Comprehensive Cancer Center, Richmond
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation
RekrutacjaFaza 1
- Virginia Commonwealth University, Richmond
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
RekrutacjaFaza 3
- Virginia Commonwealth University, Richmond
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
RekrutacjaFaza 3
- Bon Secours St. Francis Medical Oncology Center, Midlothian · 11 mi dalej
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekrutacjaFaza 3
- Bon Secours Cancer Institute at Memorial Regional Medical Center, Mechanicsville · 6 mi dalej
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekrutacjaFaza 3
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- Bon Secours Memorial Regional Medical Center, Mechanicsville · 6 mi dalej
- i 1 więcej
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekrutacjaBadanie obserwacyjne
- VCU Massey Cancer Center at Stony Point, Richmond
- Virginia Commonwealth University/Massey Cancer Center, Richmond
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
RekrutacjaBadanie obserwacyjne
- VCU Massey Comprehensive Cancer Center, Richmond
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekrutacjaBadanie obserwacyjne
- VCU Massey Comprehensive Cancer Center, Richmond
- Bon Secours Cancer Institute at St. Francis, Midlothian · 11 mi dalej
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
RekrutacjaFaza 2
- Virginia Commonwealth University, Richmond
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
RekrutacjaZapraszamy zdrowych ochotników
- Virginia Commonwealth University, Richmond
Badania dla Rak piersi w innych miastach
- New York City, NY136 badań
- Houston, TX126 badań
- Boston, MA112 badań
- Nashville, TN81 badań
- Los Angeles, CA73 badań
- Edison, NJ68 badań
- St. Louis, MO64 badań
- Queens, NY64 badań
- Durham, NC64 badań
- Chicago, IL59 badań
- Philadelphia, PA56 badań
- Dallas, TX55 badań
Inne badania w mieście Richmond
- Niedrobnokomórkowy rak płuca25 badań
- Rak prostaty19 badań
- Niewydolność serca16 badań
- Rak płuc14 badań
- Choroby układu sercowo-naczyniowego13 badań
- Rak jelita grubego i odbytnicy13 badań
- Stłuszczeniowa choroba wątroby12 badań
- Ostra białaczka szpikowa12 badań
- Nowotwór przerzutowy12 badań
- Rak płaskonabłonkowy głowy i szyi12 badań
- Czerniak11 badań
- Otyłość11 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.